Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RN7SL405P is a pseudogene of the 7SL RNA family, officially named "RNA, 7SL, cytoplasmic 405, pseudogene"[1]. Pseudogenes are nonfunctional segments of DNA that resemble functional genes but generally lack the ability to encode active RNAs or proteins[2]. While the canonical 7SL RNA forms an essential RNA component of the signal recognition particle (SRP) complex, critical for intracellular protein targeting, RN7SL405P is one of many truncated and typically nonfunctional copies of this RNA distributed throughout the human genome[6]. Pseudogenes like RN7SL405P are not considered therapeutic targets as they do not encode functional products and do not participate in recognized cellular pathways[1][2]. There are no known drugs, disease roles, biomarker functions, mechanisms of action, or safety concerns associated with RN7SL405P. Its presence reflects evolutionary history and gene duplication/loss processes in the genome, and it may complicate molecular studies due to sequence similarity with functional 7SL RNA genes[2][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SL, cytoplasmic 405, pseudogene (RN7SL405P).